
Pacific Biosciences of California PACB
€ 0.98
-6.2%
Quartalsbericht 2026-Q1
hinzugefügt 08.05.2026
Pacific Biosciences of California Kurzfristige Verbindlichkeiten 2011-2026 | PACB
Kurzfristige Verbindlichkeiten Jährlich Pacific Biosciences of California
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72.8 M | 66.3 M | 95 M | 263 M | 71.7 M | 38.5 M | 49.2 M | 26.9 M | 28.6 M | 33.8 M | 38.2 M | 31.5 M | 22.6 M | 14.7 M | 19.4 M | 20.8 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 263 M | 14.7 M | 55.8 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Co-Diagnostics
CODX
|
3.54 M | $ 1.29 | -20.86 % | $ 1.72 M | ||
|
Fulgent Genetics
FLGT
|
72.9 M | $ 15.71 | -2.96 % | $ 475 M | ||
|
Agilent Technologies
A
|
1.71 B | $ 111.77 | -1.3 % | $ 34 B | ||
|
Castle Biosciences
CSTL
|
68.7 M | $ 19.2 | 1.69 % | $ 557 M | ||
|
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | ||
|
Illumina
ILMN
|
1.55 B | $ 143.1 | -0.1 % | $ 22.8 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
5.1 M | $ 1.8 | - | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
89.8 M | $ 20.02 | -2.29 % | $ 1.07 B | ||
|
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
4.05 M | - | - | $ 9.42 M | ||
|
Lantheus Holdings
LNTH
|
333 M | $ 94.21 | -2.55 % | $ 6.36 B | ||
|
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | ||
|
Mettler-Toledo International
MTD
|
1.2 B | $ 1 034.95 | -0.67 % | $ 21.3 B | ||
|
Medpace Holdings
MEDP
|
1.34 B | $ 417.68 | -0.36 % | $ 12 B | ||
|
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | ||
|
Myriad Genetics
MYGN
|
134 M | $ 3.59 | -0.97 % | $ 332 M | ||
|
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | ||
|
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | ||
|
NeoGenomics
NEO
|
88.3 M | $ 8.26 | -1.2 % | $ 1.06 B | ||
|
Charles River Laboratories International
CRL
|
1.12 B | $ 150.9 | -5.17 % | $ 7.48 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | ||
|
National Research Corporation
NRC
|
36.6 M | $ 18.56 | -1.95 % | $ 415 M | ||
|
Natera
NTRA
|
310 M | $ 188.46 | -4.22 % | $ 18.5 B | ||
|
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | ||
|
Guardant Health
GH
|
303 M | $ 95.46 | -3.24 % | $ 12 B | ||
|
Senseonics Holdings
SENS
|
24.3 M | $ 5.76 | -1.12 % | $ 240 M | ||
|
Personalis
PSNL
|
39.6 M | $ 6.4 | -4.69 % | $ 571 M | ||
|
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
2.8 B | $ 115.74 | -1.15 % | $ 9.55 B | ||
|
Soleno Therapeutics
SLNO
|
61.4 M | $ 53.0 | 0.01 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
1.74 M | $ 2.3 | -4.56 % | $ 5.28 M | ||
|
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 251.69 | -0.92 % | $ 20.9 B | ||
|
Thermo Fisher Scientific
TMO
|
15.2 B | $ 438.03 | -2.27 % | $ 165 B | ||
|
Celcuity
CELC
|
44.2 M | $ 137.57 | 2.12 % | $ 6.43 B | ||
|
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
91.4 M | $ 49.03 | -7.4 % | $ 2.93 B | ||
|
Neogen Corporation
NEOG
|
174 M | $ 8.18 | -3.02 % | $ 1.77 B | ||
|
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 187.21 | -0.39 % | $ 20.8 B | ||
|
Waters Corporation
WAT
|
1.24 B | $ 331.36 | -0.56 % | $ 19.7 B |